An observational study in Mentally Ill Old Subjects, sponsored by University Hospital, Limoges. Completed at 1 site in France. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2015-02-13.
Sponsored by University Hospital, Limoges · Observational
2 URCC in the Limousin region will be equipped with the automated telesurveillance system. Patient will be selected by ward's geriatrician and randomized into two groups after informed consent. One group will have cameras installed and the other will not and will act as a comparison group. Patient will be assessed twice during the study, at admission in (inclusion visit) and at outcome from the URCC (end of study visit). Each assessment implies a standard geriatric assessment, a fall questionnaire, a Neuropsychiatric inventory for behavioral disturbances and a quality of life questionnaire (EQ5D). Every fall will be considered as adverse events and will therefore be listed along the study and characterized in types and number.
2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.
This study's enrollment of 350 is above the median of 250 across 482 observational studies indexed under Dementia.
Browse Dementia studies →University Hospital, Limoges is the lead sponsor of 255 studies on the registry; 36 are open to participants now.
Counted across the registry records on this site, refreshed daily.
demented old subjects
Exclusion Criteria:
Rooms of the patient of the "intervention group" will be equipped of cameras
Patient in the "non-equipped" group will have usual care
The impact of the automated telesurveillance system
The impact of the automated telesurveillance system on the incidence rate of falls with serious outcomes between the two groups during their hospitalization in URCC.
Time frame: 6 months
The impact of the system on the global rate of falls
Time frame: 6 months
This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Limoges